↓ Skip to main content

American Association for Cancer Research

Article Metrics

Coffee Consumption and the Risk of Colorectal Cancer

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, March 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#2 of 4,095)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
71 news outlets
blogs
6 blogs
twitter
446 tweeters
facebook
27 Facebook pages
googleplus
6 Google+ users
video
2 video uploaders

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
117 Mendeley
Title
Coffee Consumption and the Risk of Colorectal Cancer
Published in
Cancer Epidemiology, Biomarkers & Prevention, March 2016
DOI 10.1158/1055-9965.epi-15-0924
Pubmed ID
Authors

Stephanie L. Schmit, Hedy S. Rennert, Gad Rennert, Stephen B. Gruber

Abstract

Coffee contains several bioactive compounds relevant to colon physiology. Although coffee intake is a proposed protective factor for colorectal cancer, current evidence remains inconclusive. We investigated the association between coffee consumption and risk of colorectal cancer in 5,145 cases and 4,097 controls from the Molecular Epidemiology of Colorectal Cancer (MECC) study, a population-based case-control study in northern Israel. We also examined this association by type of coffee, by cancer site (colon and rectum), and by ethnic subgroup (Ashkenazi Jews, Sephardi Jews, and Arabs). Coffee data were collected by interview using a validated, semi-quantitative food frequency questionnaire. Coffee consumption was associated with 26% lower odds of developing colorectal cancer [OR (drinkers vs. non-drinkers), 0.74; 95% confidence interval (CI), 0.64-0.86; P < 0.001]. The inverse association was also observed for decaffeinated coffee consumption alone (OR, 0.82; 95% CI, 0.68-0.99; P = 0.04) and for boiled coffee (OR, 0.82; 95% CI, 0.71-0.94; P = 0.004). Increasing consumption of coffee was associated with lower odds of developing colorectal cancer. Compared with <1 serving/day, intake of 1 to <2 servings/day (OR, 0.78; 95% CI, 0.68-0.90; P < 0.001), 2 to 2.5 servings/day (OR, 0.59; 95% CI, 0.51-0.68; P < 0.001), and >2.5 servings/day (OR, 0.46; 95% CI, 0.39-0.54; P < 0.001) were associated with significantly lower odds of colorectal cancer (Ptrend < 0.001), and the dose-response trend was statistically significant for both colon and rectal cancers. Coffee consumption may be inversely associated with risk of colorectal cancer in a dose-response manner. Global coffee consumption patterns suggest potential health benefits of the beverage for reducing the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev; 25(4); 634-9. ©2016 AACR.

Twitter Demographics

The data shown below were collected from the profiles of 446 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Austria 1 <1%
Unknown 114 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 18%
Student > Master 14 12%
Student > Ph. D. Student 13 11%
Other 9 8%
Student > Doctoral Student 8 7%
Other 29 25%
Unknown 23 20%
Readers by discipline Count As %
Medicine and Dentistry 36 31%
Agricultural and Biological Sciences 13 11%
Nursing and Health Professions 11 9%
Biochemistry, Genetics and Molecular Biology 7 6%
Chemistry 4 3%
Other 14 12%
Unknown 32 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 892. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2021.
All research outputs
#11,679
of 19,157,212 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#2
of 4,095 outputs
Outputs of similar age
#233
of 274,047 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#1
of 68 outputs
Altmetric has tracked 19,157,212 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,095 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,047 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.